3 days Should You Buy, Sell or Hold J&J Stock Ahead of Q4 Earnings? Zacks
JNJ’s Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Tremfya. It remains to be seen if MedTech sales improved.
Earnings · Johnson & Johnson (JNJ)
X